Akebia Therapeutics, Inc. (AKBA) vs Biodesix, Inc. (BDSX)
A side-by-side comparison of Akebia Therapeutics, Inc. and Biodesix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKBA
Akebia Therapeutics, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
BDSX
Biodesix, Inc.
$28.45HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — AKBA vs BDSX
growth of $100 · dividends reinvested · last 6yAKBA -62.4% (-15.0%/yr)BDSX -88.7% (-30.4%/yr)AKBA compounded faster over this window
AKBA BDSX
AKBA vs BDSX: by the numbers
- •AKBA is the larger company ($241M vs $232M market cap).
- •Both run net losses; AKBA's is the smaller (-13.54% vs -26.97% net margin).
- •BDSX grew revenue faster over the past five years (5.99% vs -0.26% CAGR).
Metrics side by side
Valuation
| Metric | AKBA | BDSX |
|---|---|---|
| P/S ratio | 1.10 | 2.25 |
| P/B ratio | 9.63 | 25.33 |
| FCF yield | 16.67% | N/A |
Profitability
| Metric | AKBA | BDSX |
|---|---|---|
| Gross margin | 79.48% | 82.50% |
| Operating margin | 9.95% | -31.37% |
| Net margin | -13.54% | -26.97% |
| ROE | -118.58% | -303.61% |
| ROIC | -7.08% | -25.73% |
Growth (annualized)
| Metric | AKBA | BDSX |
|---|---|---|
| Revenue CAGR (5Y) | -0.26% | 5.99% |
| Total return CAGR (5Y) | -20.07% | -28.49% |
Frequently asked
- Which has grown faster, AKBA or BDSX?
- Over the past five years, BDSX grew revenue faster — AKBA at a -0.26% CAGR versus BDSX at 5.99%.
- How have AKBA and BDSX total returns compared?
- Over the past 5 years, AKBA delivered -20.07% and BDSX delivered -28.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Akebia Therapeutics ROEBiodesix ROEAkebia Therapeutics operating marginBiodesix operating marginAkebia Therapeutics revenue growthBiodesix revenue growthAkebia Therapeutics free cash flowBiodesix free cash flow
Akebia Therapeutics & Biodesix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.